✦ LIBER ✦
High Numbers of Tumor-Associated Macrophages Have an Adverse Prognostic Value That Can Be Circumvented by Rituximab in Patients With Follicular Lymphoma Enrolled Onto the GELA-GOELAMS FL-2000 Trial
✍ Scribed by Canioni, D.; Salles, G.; Mounier, N.; Brousse, N.; Keuppens, M.; Morchhauser, F.; Lamy, T.; Sonet, A.; Rousselet, M.-C.; Foussard, C.; Xerri, L.
- Book ID
- 118161275
- Publisher
- American Society of Clinical Oncology
- Year
- 2008
- Tongue
- English
- Weight
- 374 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0732-183X
No coin nor oath required. For personal study only.